BLU, NEPT & ROOT Upcoming Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Encourages Investors to Contact the Firm Biotech Investing
FINAL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages BELLUS Health Inc. Investors with Large Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action - BLU Biotech Investing
Bristol Myers Squibb Presents New Research at ASCO and EHA 2021 Featuring Novel Approaches and Demonstrating Significant Progress to Improve Survival in Cancer and Blood Disorders Biotech Investing
DEADLINE ALERT for NEPT, BLU, ACAD, PINS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders Biotech Investing
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
Deadline of May 17, 2021 for BELLUS Health Inc. Class Action - Bronstein, Gewirtz & Grossman, LLC Encourages Investors With Losses Exceeding $200K to Actively Participate Biotech Investing
BELLUS Health to Participate in the 2021 RBC Capital Markets Global Healthcare Conference Biotech Investing
Bellus Health, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm Biotech Investing
SOLITON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SOLY and Encourages Investors to Contact the Firm Biotech Investing
